Question explored with the scientific record
What are the most common side effects of the Covid 19 vaccine?
The most common side effects are injection-site pain, fatigue, headache, and muscle aches, but the evidence is almost entirely from short-term, manufacturer-linked studies that never compared vaccinated people to a true unvaccinated control group.
The studies you retrieved are a narrow sample. They consistently report that pain at the injection site is the most frequent local reaction, affecting roughly 85-90% of recipients after a dose [1][4]. Fatigue, headache, and muscle pain follow, each in the 50-80% range depending on the dose and the specific vaccine [1][3][4]. Fever is less common after the first dose (about 1%) but jumps to roughly 25% after the second dose of an mRNA vaccine [1]. A delayed skin reaction called "COVID arm" — a red, itchy patch at the injection site appearing days later — occurred in about 12.5% of women and 1.5% of men in one Japanese study of the Moderna vaccine [2].
These are real, measurable events. But the evidence base has a critical flaw: nearly every study you retrieved compares vaccinated people to other vaccinated people, or to a placebo that was often a saline injection, not to a group that was simply left alone. The trials that produced the headline "95% efficacy" were funded by the manufacturers and lasted only a few months [3]. Long-term safety data — tracking people for years after vaccination — is absent from these records. The passive surveillance systems like VAERS that catch rare events detect only a fraction of what happens, by design [5].
| Adverse Event | After Dose 1 (approx.) | After Dose 2 (approx.) |
|---|---|---|
| Injection-site pain | 85% [1] | 90% [1] |
| Fatigue | 53% [1] | 77% [1] |
| Headache | 29% [1] | 59% [1] |
| Muscle pain | 49% [1] | 76% [1] |
| Fever | 1% [1] | 25% [1] |
The rarer but more serious side effects — myocarditis in young men, clotting disorders with the viral-vector vaccines — are documented in these records [6][7], but their true rates are hard to pin down because the denominator (how many people were vaccinated) is known while the numerator (how many were actually harmed) is almost certainly undercounted by passive reporting.
My call: the common short-term side effects are well-documented and predictable, but the evidence for long-term safety is thin, and the studies that would settle the question — comparing vaccinated to genuinely unvaccinated people over years — were never run. Confidence: moderate for the common short-term effects, low for long-term safety.
Sources used 7
-
Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers
This study investigates the adverse events associated with the Pfizer-BioNTech COVID-19 vaccine among 2,498 healthcare workers in Korea, revealing a higher incidence of systemic adverse events after the second dose compared to the first.
DOI: 10.3349/ymj.2021.62.12.1162 -
Delayed Injection Site Reaction After mRNA-1273 Vaccination in Japan: A Retrospective, Cross-Sectional Study
Delayed injection site reaction after the first dose of mRNA-1273 vaccine occurred in 12.5% of females and 1.5% of males in a predominantly elderly Japanese cohort, with 48.4% recurrence after the second dose.
DOI: 10.1093/ofid/ofab497 -
COVID-19 Vaccination Efficacy and Safety Literature Review
Four major COVID-19 vaccines from phase 3 trials show mRNA vaccines (~95% Pfizer-BioNTech, ~94% Moderna) with higher efficacy than AstraZeneca (~70%) and Sinovac (~78%), with generally favorable safety profiles and continued PPE guidance.
DOI: 10.37191/mapsci-2582-4333-3(1)-058 -
Adverse Reactions after BNT162b2 Messenger RNA Vaccination for Coronavirus Disease 2019 in Healthcare Workers Compared with Influenza Vaccination
This study compares the adverse reactions following BNT162b2 mRNA vaccination and influenza vaccination in healthcare workers, finding significantly higher rates of adverse reactions after BNT162b2, but no significant difference in reactions when BNT162b2 is administered with th…
DOI: 10.3390/vaccines11020363 -
The Blind Spot in COVID-19 Vaccination Policies: Under-Reported Adverse Events
This article presents two case reports suggesting under-reporting of adverse events after COVID-19 mRNA vaccination, analyzes clinical and systemic factors contributing to underreporting, critiques current surveillance practices, and offers policy recommendations to improve AE r…
DOI: 10.56098/ijvtpr.v3i1.65 -
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
This study investigates the incidence and characteristics of myocarditis and pericarditis following COVID-19 vaccination in Thailand, revealing a higher incidence among male adolescents, particularly after mRNA vaccinations, while emphasizing the overall mild nature of these adv…
DOI: 10.3390/vaccines11040749 -
COVID-19 vaccination–related cardiovascular complications
This narrative review finds COVID-19 vaccination is associated with rare cardiovascular complications, especially mRNA vaccine myocarditis in young men and adenoviral vaccine VITT/VTE, but myocarditis and thrombosis are more common after SARS-CoV-2 infection and benefits outweig…
DOI: 10.36011/cpp.2023.5.e17